ProPhase Labs, Inc.
PRPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -84.7% | -63.8% | 55.2% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -2.2% | 36.6% | 57.6% | 41.5% |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | -477.6% | -33.4% | 23.4% | 14.4% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -788.2% | -37.8% | 15.1% | 7.9% |
| EPS Diluted | -2.61 | -0.98 | 1.02 | 0.4 |
| % Growth | -166.3% | -196.1% | 155% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |